Episode #6 is being produced in honour of World Keratoconus Day, celebrated around the world on November 10th. This episode is jam-packed with crucial insight from company Avellino - a leader in precision medicine, is making a global impact in genetics and bringing innovative diagnostics, therapies, and AI-driven data processing to patient care. A special thank you goes out to our 2 guests this week: 

Joe Boyd: Mr. Boyd is the Global Head of Sales and Marketing for Avellino, a global leader in gene therapy and molecular diagnostics at the forefront of precision medicine for eye care. He has more than 20 years of experience in life sciences and medical devices and is a sought-after speaker in the science and medical industry. 

Brandon Ayres, MD: Brandon Ayres, MD is a board certified ophthalmologist at Wills Eye Hospital who specializes in all forms of corneal transplantation and all types of refractive and cataract surgery, including LASIK. Dr. Ayres also treats infectious diseases of the eye and ocular surface disease (dry eye).  He has an interest in the diagnosis and treatment of keratoconus and has been involved in several FDA trials investigating new treatments for the condition.

Avellino has launched its first genetic test, AvaGen™.  AvaGen™ is an eye test that confidently empowers eyecare professionals to protect and preserve vision by providing personalized genetic data that accurately quantifies the risk or presence of sight-threatening conditions.